Clinical Trials Browser

NCT07475923 2026-04-16

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Withdrawn

Breast

Breast Neoplasms

NCT01272037 2026-04-13

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Phase 3 Active not recruiting

5,018 enrolled 14 charts

Breast

Carcinoma, Intraductal, Noninfiltrating

NCT03387553 2026-03-27

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

31 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02089100 2026-03-19

STEREO-SEIN

Phase 3 Active not recruiting

154 enrolled

Breast

Breast Neoplasms

NCT03978663 2026-02-20

TRIO

Phase NA Active not recruiting

40 enrolled

Breast

High-Risk Cancer

NCT07217990 2026-02-17

NoCUT-BC

Phase 1/2 Not yet recruiting

84 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07407244 2026-02-17

AKRA

Phase NA Active not recruiting

268 enrolled

Breast

Breast Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Breast

Breast Neoplasms

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Phase EARLY_PHASE1 Active not recruiting

34 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06739655 2026-02-04

PRADAIIBE

Phase NA Recruiting

180 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT07383818 2026-02-03

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

Phase 2 Recruiting

111 enrolled

Breast

Breast Neoplasms

NCT06498154 2025-12-19

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

Phase 2 Recruiting

200 enrolled

Breast

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Phase 2 Active not recruiting

35 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT07254858 2025-11-28

CISN-L

Phase 2 Not yet recruiting

302 enrolled

Breast

Breast Neoplasms

NCT00462696 2025-10-06

ISNA-Sein

Phase NA Completed

16 enrolled 2 charts

Breast

Breast Neoplasms

NCT00872625 2025-09-30

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Phase 1 Completed

26 enrolled

Breast

Breast Neoplasms

NCT06611813 2025-08-12

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Phase 2 Recruiting

30 enrolled

Breast

Breast Neoplasms

NCT06874933 2025-08-12

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

Phase 2 Recruiting

35 enrolled

Breast

Breast Neoplasms

NCT06876636 2025-07-29

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

Phase NA Active not recruiting

99 enrolled

Breast

Breast Cancer Metastatic

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Phase 2 Recruiting

27 enrolled

Breast

Breast Neoplasms

NCT06977893 2025-05-18

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

Phase 3 Recruiting

194 enrolled

Breast

Breast Neoplasms

NCT06190600 2025-04-30

SPORTNATHy

Phase NA Active not recruiting

40 enrolled

Breast

Breast Neoplasms, Motor Activity